Related references
Note: Only part of the references are listed.Increasing omission of radiation therapy and sentinel node biopsy in elderly patients with early stage, hormone-positive breast cancer
Nicole Christian et al.
BREAST JOURNAL (2020)
Defining clinicopathological and radiological features of breast cancer in women under the age of 35: an epidemiological study
Matthew G. Davey et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2020)
Axillary ultrasound-guided core biopsy in breast cancer: identifying higher nodal burden and more aggressive clinicopathological characteristics
Michael R. Boland et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer
Scott Kizy et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Are we choosing wisely in elderly females with breast cancer?
Esteban Calderon et al.
AMERICAN JOURNAL OF SURGERY (2019)
Choosing Wisely campaigns globally: A shared approach to tackling the problem of overuse in healthcare
Karen B. Born et al.
JOURNAL OF GENERAL AND FAMILY MEDICINE (2019)
Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ
Brigid K. Killelea et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
J. A. Alberro et al.
LANCET ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery
San-Gang Wu et al.
FRONTIERS IN ONCOLOGY (2018)
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis The ACOSOG Z0011 (Alliance) Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial
Harry D. Bear et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis
Shuyin Liang et al.
JOURNAL OF GERIATRIC ONCOLOGY (2017)
New methods for estimating follow-up rates in cohort studies
Xiaonan Xue et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials
Michael F. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound
Amy E. Cyr et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2016)
Can axillary node dissection be safely omitted in the elderly? A retrospective study on axillary management of early breast cancer in older women
Emanuela Esposito et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Pathology of Perineural Spread
Ian S. Brown
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2016)
Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance
Zhanhong Chen et al.
ONCOLOGY LETTERS (2015)
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
Terri Patricia McVeigh et al.
EUROPEAN JOURNAL OF CANCER (2014)
Is imaging the future of axillary staging in breast cancer?
M. Ahmed et al.
EUROPEAN RADIOLOGY (2014)
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis
Josh J. Carlson et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Breast cancer in the elderly-Should it be treated differently?
Petra Tesarova
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2013)
Current Operative Management of Breast Cancer: An Age of Smaller Resections and Bigger Cures
Jackw. Rostas et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
Gabriele Martelli et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
D2-40 lymphatic marker for detecting lymphatic invasion in thin to intermediate thickness melanomas: Association with sentinel lymph node status and prognostic value-A retrospective case study
Laurel E. Fohn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer
D. Craig Allred
MODERN PATHOLOGY (2010)
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S. Albain et al.
LANCET ONCOLOGY (2010)
Staging MR Lymphangiography of the Axilla for Early Breast Cancer: Cost-Effectiveness Analysis
Pari V. Pandharipande et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
David N. Krag et al.
LANCET ONCOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surgical management of breast cancer
Bianca Vazquez et al.
SEMINARS IN ONCOLOGY (2007)
Treatment of lymph-node-negative, oestrogen-recept-postive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials
B Fisher et al.
LANCET (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age
JY Pierga et al.
BREAST (2004)
Barriers to clinical trial participation by older women with breast cancer
MM Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Participation of patients 65 years of age or older in cancer clinical trials
JH Lewis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
